Clinical Trial Update: Symbicort Turbuhaler 30/60 Clinical Experience Investigation

View source ↗

Summary

A completed clinical trial update summarizing clinical experience with Symbicort Turbuhaler 30/60 in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort Turbuhaler 30/60 (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Status: COMPLETED